Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

56.700
-1.200-2.07%
Volume:18.25M
Turnover:1.03B
Market Cap:233.38B
PE:41.72
High:57.200
Open:56.100
Low:55.550
Close:57.900
52wk High:58.000
52wk Low:28.480
Shares:4.12B
HK Float Shares:4.12B
Volume Ratio:0.74
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.359
ROE:11.38%
ROA:7.60%
PB:4.15
PE(LYR):41.72
PS:8.44

Loading ...

WUXI BIO Contracts Share Base by 0.70% in September 2026 Following HKD 1.27 Billion Buybacks

Bulletin Express
·
Yesterday

Wuxi Biologics (Cayman) Stock Slips 2.1% in Hong Kong

Dow Jones
·
Yesterday

HK Movers | Biopharma Stocks Fall Across the Board, GENSCRIPT BIO Plunges Over 14%, JOINN Drops More Than 12%

Tiger Newspress
·
Yesterday

Movement Alert|WUXI BIO Falls 3.02% in Regular Trading, CXO Sector Retreat Weighs on Sentiment

Market Focus
·
Yesterday

Movement Alert|WUXI BIO Falls 3.11% in Regular Trading, CXO Sector Pulls Back Collectively

Market Focus
·
Yesterday

How FDA Inspection Success At WuXi Biologics Stock Has Changed Its Investment Story

Simply Wall St.
·
Yesterday

CRO Sector Stocks Lead Afternoon Gains; WuXi Bio and Pharmaron Each Rise Over 4%

Deep News
·
Oct 06

Hong Kong Stocks Climb, Led by Pharmaceutical, Tech Stocks

Reuters
·
Oct 06

JPMorgan Unfazed by Rising Rates Impact on China Healthcare, Remains Bullish on Biotech and CXO

Stock News
·
Oct 06

Hong Kong Stock Movers: CRO Concept Stocks Lead Gains as JPMorgan Says Rate Hikes Are Not a Major Concern, Order Growth to Underpin Future Earnings

Stock News
·
Oct 06

HK Movers | Innovative Drug Stocks Rally Broadly; GENSCRIPT BIO Jumps Over 6% to New High

Tiger Newspress
·
Oct 06

Movement Alert|WUXI BIO Intraday Rise 3.16%

Market Focus
·
Oct 06

Wuxi Biologics (Cayman) Stock Advances 1.6% in Hong Kong

Dow Jones
·
Oct 05

Wuxi Biologics (Cayman) Stock Slides 2.7% in Hong Kong

Dow Jones
·
Oct 02

Movement Alert|WUXI BIO Falls 3.39% in Regular Trading, Trading at HK$54.3

Market Focus
·
Oct 02

Wuxi Biologics (Cayman) Stock Rises 4.8% in Hong Kong

Dow Jones
·
Sep 30

Goldman Sachs: Asian CDMOs Enter a Structural Growth Cycle, with Peptides, ADCs, Oligonucleotides, and AIDD as New Engines

Stock News
·
Sep 30

Movement Alert|WUXI BIO Rises 3.27% in Regular Trading, Broker Upgrades and Policy Tailwinds Fuel CXO Rally

Market Focus
·
Sep 30

Southbound Trading Update: Net Buy of HKD 15 Million, Increased AIA (01299) Stake by Over HKD 800 Million, Sold Off Alibaba (09988) Over HKD 500 Million

Stock News
·
Sep 29

Movement Alert|WUXI BIO Rises 3.28% in Regular Trading, CXO Sector Boosted by Strong Earnings and Policy Tailwinds

Market Focus
·
Sep 29